US drug developer Cytokinetics today announced that Myqorzo (aficamten) is now available for prescription in 5mg, 10mg, 15mg ...

US biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, Antheia, today announced it has ...

Gene editing company Intellia Therapeutics has announced that the US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug application (IND) for the ...

UK pharma major GSK today announced that its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine, Arexvy, has been approved by the European Commission (EC) for use in adults aged 18 years ...

Privately-held German drugmaker Boehringer Ingelheim has announced a license and collaboration agreement to develop SIM0709, a pre-clinical TL1A/IL23p19 bispecific antibody from China’s Simcere ...

In a significant ruling for pharmaceutical regulation in India, the Delhi High Court has reinstated the Indian government's ...

Servier, an independent pharma governed by a foundation, has published its financial results for the 2024/25 financial year.

Swiss pharma giant Roche has announced positive topline results from CT388-103, a Phase II trial of CT-388, an investigational dual GLP-1/GIP receptor agonist being developed for the treatment of ...

Swedish women’s health specialist Gedea Biotech today announces a planned chief executive (CEO) transition. After close to ...

US biotech Fortitude Biomedicines has emerged from stealth with $13 million in seed funding to develop a hybrid biologics ...

Advicenne’s shares rose 6% to 1.76 euros this morning, on the news it has obtained both marketing authorization (MA) and ...

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on ways to strengthen domestic supply chains for ...